| Literature DB >> 25267439 |
Laure Michel1, Melanie Chesneau2, Philippe Manceau3, Athenais Genty3, Alexandra Garcia3, Marion Salou3, Annie Elong Ngono3, Annaïck Pallier2, Marylène Jacq-Foucher4, Fabienne Lefrère4, Sandrine Wiertlewski4, Jean-Paul Soulillou5, Nicolas Degauque5, David-Axel Laplaud6, Sophie Brouard7.
Abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) typically characterized by the recruitment of T cells into the CNS. However, certain subsets of B cells have been shown to negatively regulate autoimmune diseases and some data support a prominent role for B cells in MS physiopathology. For B cells in MS patients we analyzed subset frequency, cytokine secretion ability and suppressive properties. No differences in the frequencies of the B-cell subsets or in their ability to secrete cytokines were observed between MS and healthy volunteers (HV). Prestimulated B cells from MS patients also inhibited CD4(+)CD25(-) T cell proliferation with a similar efficiency as B cells from HV. Altogether, our data show that, in our MS patient cohort, regulatory B cells have conserved frequency and function.Entities:
Keywords: B cells; Multiple sclerosis; Regulation
Mesh:
Substances:
Year: 2014 PMID: 25267439 DOI: 10.1016/j.clim.2014.09.011
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969